Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2005
09/22/2005US20050208492 Regulation of human serine/threonine kinase
09/22/2005US20050208466 Method of selective isolation or visualization of target cells differentiated from embryonic cells or kit for visualization
09/22/2005US20050208151 Treatment of rheumatoid arthritis with FLIP antagonists
09/22/2005US20050208142 Production of nanoparticles having a defined number of ligands
09/22/2005US20050208138 Injection of a biocompatible polymer, polysaccharide or polyamino acid, a cross-linker, and therapeutic agent into tumor; hydrogel formed in the tumor retains the therapeutic agent; drug delivery method; sustained releasing the biodrug
09/22/2005US20050208074 Anticancer agents; gene therapy; trimers; host cells; genomes
09/22/2005US20050208065 Immunogenic compositions for induction of anti-tumor immunity
09/22/2005US20050208064 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
09/22/2005US20050208052 Screening for agonists/antagonists of interleukins; influenza virus; RNA interference; kits
09/22/2005US20050208046 TWEAK receptor
09/22/2005US20050208040 Polynucleotides and polypeptides encoded thereby
09/22/2005US20050208032 Oral administration of therapeutic agent coupled to transporting agent
09/22/2005US20050208031 Identify agonist exhibiting pharmacologic molecular biologic inhibition effective against the activity of the iPLA2 beta and iPLA2 gamma isoforms; transfect the cells with siRNA prior to induction of differentiation; observe if down regulation inhibits or controls adipocyte chemisty; obesity therapy
09/22/2005US20050208030 Myocardial grafts and cellular compositions useful for same
09/22/2005US20050208023 Inhibiting tumor angiogenesis by engineered over expression of Von Hippel-Lindau; nucleic acid vector is in a viral capsid; administered intratumorally
09/22/2005US20050208022 Gene introduced into a retinal cell, encoding photosensitive protein; horizontal cells, amacrine cells, bipolar cells, and ganglion cells; photoreceptor cell degeneration; retinitis pigmentosa, macular degeneration, age-related macular degeneration
09/22/2005US20050208021 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
09/22/2005US20050208020 Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines
09/22/2005US20050208010 Genes from Chromosome 3, 5 and 11 involved in premature canities
09/22/2005US20050207988 Polysaccharides for pulmonary delivery of active agents
09/22/2005CA2560046A1 Methods for suppressing tumor proliferation
09/22/2005CA2559060A1 Phospholipases, nucleic acids encoding them and methods for making and using them
09/22/2005CA2559055A1 Modified oncolytic viruses
09/22/2005CA2558771A1 Multiple promoter expression cassettes for simultaneous delivery of rnai agents
09/22/2005CA2557633A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
09/21/2005EP1577391A1 Neutrokine alpha
09/21/2005EP1577387A1 Preventives/remedies for cancer
09/21/2005EP1576370A2 Methods of diagnosing and treating diabetes and insulin resistance
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576118A2 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
09/21/2005EP1576117A2 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells
09/21/2005EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576001A2 Endothelial cell specifically binding peptides
09/21/2005EP1575993A2 Methods for treating patients and identifying therapeutics
09/21/2005EP1575987A2 Conjugates of membrane translocating agents and pharmaceutically active agents
09/21/2005EP1575985A2 INHIBITION OF Ii EXPRESSION IN MAMMALIAN CELLS
09/21/2005EP1575976A2 Methods and compositions for therapeutic use of rna interference
09/21/2005EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders
09/21/2005EP1575643A2 Directly injectable formulations which provide enhanced cryoprotection of cell products
09/21/2005EP1575611A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy
09/21/2005EP1575607A1 Vanilloid receptor-2 ligands for treating anxiety or depression
09/21/2005EP1575602A2 Methods for treating cancer using porimin as a target
09/21/2005EP1575526A2 Dna vaccines encoding heat shock proteins
09/21/2005EP1575518A2 Compositions, organisms and methodologies employing a novel human kinase
09/21/2005EP1575510A2 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575498A2 Antisense modulation of microsomal prostaglandin e2 synthase expression
09/21/2005EP1575481A2 Methods to increase or decrease bone density
09/21/2005EP1575364A2 Methods and compositions using compounds from fetal cells and tissues to improve condition of skin
09/21/2005EP1575354A1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure
09/21/2005EP1294877B1 Cgi-69 compositions and methods of use
09/21/2005EP1263936B1 Altered strain of the modified vaccinia virus ankara (mva)
09/21/2005EP1263446B1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
09/21/2005EP1192256B1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005EP0804565B1 Tetracycline-regulated transcriptional modulators
09/21/2005EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/21/2005EP0792364B1 Lgmd gene coding for a calcium dependent protease
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005CN1672046A Method for identifying substances
09/21/2005CN1671866A PTHrP-based prediction and diagnosis of bone disease
09/21/2005CN1671863A Central airway administration for systemic delivery of therapeutics
09/21/2005CN1671851A Flavivirus vaccine delivery system
09/21/2005CN1671845A Immunogenic sequences
09/21/2005CN1671844A Antigenic neisserial peptides
09/21/2005CN1671742A Use of HMGB1 in the treatment of tissue damage and/or to promote tissue repair
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671733A Compositions and methods for WT1 specific immunotherapy
09/21/2005CN1671730A Oligonucleotide-containing pharmacological compositions and their use
09/21/2005CN1671729A Control sequences of the human Corin gene
09/21/2005CN1671425A ACE2 activation for treatment of heart, lung and kidney disease and hypertension
09/21/2005CN1671424A Decoy composition for treating and preventing inflammatory disease
09/21/2005CN1671423A Novel chimeric CD154
09/21/2005CN1671415A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
09/21/2005CN1671414A CpG formulations and related methods
09/21/2005CN1671407A Compositions and methods for treating diabetes
09/21/2005CN1670208A Cancer-inhibiting gene and its application in preparing anticancer medicine combined with chemical therapeutic medicine
09/21/2005CN1670206A Protease subunit C7-I of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670205A Protease subunit C3 of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670204A Autolytic enzyme of streptococcus pneumoniae, its coding nucleic acid and application
09/21/2005CN1670202A Microsome GST-1 of clonorchis sinensis, its coding acid and application
09/21/2005CN1670201A Fumaric reductase Ip subunit of liver fluke, its coding acid and application
09/21/2005CN1670200A Lactate dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670199A I type aldehyde dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670198A Thermostable type cytoplasm malic dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670197A Arginase of Japanese blood fluke, its coding nucleic acid and application
09/21/2005CN1670196A Adenylate kinase 3 of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670195A Propionyl-CoA carboxylase of clonorchis sinensis, its coding nucleic acid and application thereof
09/21/2005CN1670194A Calcineurin of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1669585A Tumor therapeutic agent and usage thereof
09/21/2005CN1219881C Human protooncogene and protein encoded therein
09/20/2005US6947845 Method of identifying molecules that bind to the large ribosomal subunit
09/20/2005US6946456 Administering compounds which inhibit heat shock protein 90 proteins; methods block Rb negative or deficient cells in the G2/M phase of the cell cycle and rapidly causes their destruction
09/20/2005US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance
09/20/2005US6946296 Methods and compositions for polypeptide engineering
09/20/2005US6946259 Compositions and methods for treating cells having double minute DNA
09/20/2005US6946134 improved shelf-life; produced in glycosylation-/protease-free yeast cultures
09/20/2005US6946132 Pure dnaJp1 peptide in a carrier; dnaJ is a heat shock protein; also immunoassay for identifying persons who are predisposed to develop rheumatoid arthritis
1 ... 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 ... 870